AIM
ABBV icon

Access Investment Management’s AbbVie ABBV Stock Holding History

Access Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.9K Hold
238
– – 0.02% 87
2026
Q1 		$51.8K Hold
238
– – 0.01% 100
2025
Q4 		$55.1K Hold
238
– – 0.01% 94
2025
Q3 		$55.1K Hold
238
– – 0.01% 94
2025
Q2 		$44.2K Buy
+238
New +$44.2K 0.01% 98

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Access Investment Management's ABBV Position: Q2 2026 in Review

Access Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 238 shares worth $59.9K. The position accounts for 0.02% of the portfolio, ranked #87.

Access Investment Management first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Access Investment Management held 238 shares of AbbVie worth $59.9K as of Q2 2026.
  • Access Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.02% of Access Investment Management's portfolio in Q2 2026, its #87 holding.
  • Access Investment Management first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Access Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.